Medicine & Life Sciences

1. Pharmacists 100%
2. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 78%
3. Behavioral Symptoms 61%
4. General Practice 49%
5. Antipsychotic Agents 46%
6. Dementia 42%
7. Primary Health Care 39%
8. Systematic Reviews 37%
9. Psychology 34%
10. Randomized Controlled Trials 34%
11. Hemoglobins 30%
12. Pharmaceutical Preparations 20%
13. Delivery of Health Care 18%
14. Sodium-Glucose Transporter 2 Inhibitors 18%
15. Databases 18%
16. 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide 18%
17. Placebos 17%
18. Symporters 17%
19. Body Weight Changes 15%
20. Medical Subject Headings 14%
21. Focus Groups 13%
22. General Practitioners 13%
23. Gray Literature 12%
24. Hypoglycemic Agents 12%
25. Hyperglycemia 11%
26. Fasting 10%
27. Communication Barriers 9%
28. Type 2 Diabetes Mellitus 9%
29. Community Health Services 9%
30. Health Services 8%
31. MEDLINE 8%
32. Politics 8%
33. Pharmacies 8%
34. Glucose 7%
35. Chronic Disease 7%
36. England 7%
37. Quality of Life 6%
38. Caregivers 6%
39. Prescriptions 6%
40. Communication 5%
41. Therapeutics 5%